...
首页> 外文期刊>Journal of International Medical Research >Household Transmission of Influenza (H1N1-2009) in Japan: Age-Specificity and Reduction of Household Transmission Risk by Zanamivir Treatment
【24h】

Household Transmission of Influenza (H1N1-2009) in Japan: Age-Specificity and Reduction of Household Transmission Risk by Zanamivir Treatment

机译:日本的家庭流感传播(H1N1-2009):年龄特异性和扎那米韦治疗减少家庭传播风险

获取原文
           

摘要

This study investigated household transmission data for influenza (H1N1-2009) in Japan in order to quantify the age-specific risk of infection and estimate the impact of antiviral treatment on the risk of household transmission. Among a total of 1547 households, involving 4609 household contacts, the secondary attack ratio (SAR) was estimated to be 11.4%. School children aged 5 – 18 years dominated the index cases. Age-specific infectiousness and susceptibility were highest among 0 – 4-year olds, with SAR estimated at 19.4% and 29.6%, respectively. Zanamivir treatment within 24 and 24 – 48 h of illness onset in index cases, respectively, reduced the risk of household transmission to 0.57 (95% CI 0.44, 0.73) and 0.58 (95% CI 0.38, 0.86) times that among those receiving the same treatment at > 48 h and those not receiving treatment. The preventive performance of antiviral treatment and prophylaxis should be further examined in randomized controlled trials.
机译:这项研究调查了日本流行性感冒(H1N1-2009)的家庭传播数据,以便量化特定年龄段的感染风险,并估计抗病毒治疗对家庭传播风险的影响。在涉及4609个家庭联系的1547户家庭中,二次攻击率(SAR)估计为11.4%。 5至18岁的小学生占主导地位。年龄特定的传染性和易感性在0至4岁的人群中最高,SAR分别估计为19.4%和29.6%。在指标病例中,扎那米韦在发病后24和24-48 h内的治疗分别将家庭传播的风险降低到接受该药物治疗者的0.57倍(95%CI 0.44,0.73)和0.58(95%CI 0.38,0.86)。在48小时以上未接受治疗的患者均接受同样的治疗。在随机对照试验中应进一步检查抗病毒治疗的预防性能和预防措施。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号